Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eye Protocol”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00504205
What this trial is testing

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Astex Pharmaceuticals, Inc. 30
Not applicableLooking for participantsNCT07033741
What this trial is testing

Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms

Who this might be right for
Depression, AnxietyPost-traumatic Stress SymptomsDissociation+1 more
University of Turin, Italy 40
Not applicableStudy completedNCT05741450
What this trial is testing

A Clinical Comparison of Two Soft Contact Lenses

Who this might be right for
MyopiaHyperopia
CooperVision, Inc. 45
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Not applicableApproved For MarketingNCT02189720
What this trial is testing

Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome

Who this might be right for
Congenital Myasthenic SyndromeLambert-Eaton Myasthenic SyndromeNystagmus, Acquired
Catalyst Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07173803
What this trial is testing

The Progressive Supranuclear Palsy Clinical Trial Platform

Who this might be right for
Progressive Supranuclear Palsy(PSP)
Adam Boxer 440
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Large-scale testing (Phase 3)Study completedNCT04683796
What this trial is testing

Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease

Who this might be right for
Dry Eye Disease
Mahidol University 96
Early research (Phase 1)UnknownNCT00023816
What this trial is testing

Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Not applicableUnknownNCT06159881
What this trial is testing

Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus

Who this might be right for
Keratoconus
Instituto de Oftalmología Fundación Conde de Valenciana 20
Not applicableLooking for participantsNCT07571538
What this trial is testing

VisionApp - Ghosting

Who this might be right for
Diplopia, Monocular
Indiana University 12
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Not applicableUnknownNCT01333345
What this trial is testing

Post-Implant Performance of the EC-3 IOL

Who this might be right for
Cataract
Aaren Scientific Inc. 100
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Not applicableStudy completedNCT00559234
What this trial is testing

Potential Research Participants for Future Studies of Inherited Eye Diseases

Who this might be right for
CataractGlaucomaRetinitis Pigmentosa+2 more
National Eye Institute (NEI) 400
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Not applicableLooking for participantsNCT04140734
What this trial is testing

Spacer Graft Study

Who this might be right for
Eyelid DiseasesEyelid Droop
Montefiore Medical Center 100
Not applicableUnknownNCT06262737
What this trial is testing

Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol

Who this might be right for
Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
University Hospital, Clermont-Ferrand 50
Not applicableStudy completedNCT02293174
What this trial is testing

Retinal Fundus Camera Evaluation

Who this might be right for
Normal Healthy Subjects With no Known Ocular Diseases
Topcon Medical Systems, Inc. 10
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Next Page